We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEM icon
401
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.7B
$43.4M 0.04%
1,452,443
-246,194
-14% -$7.34M
MCO icon
402
Moody's
MCO
$83.1B
$43.1M 0.04%
124,011
-10,999
-8% -$3.49M
OMC icon
403
Omnicom Group
OMC
$23.2B
$42.9M 0.04%
450,610
+134,458
+43% +$12.5M
MET icon
404
MetLife
MET
$61.7B
$42.8M 0.04%
757,472
-27,274
-3% -$1.51M
ALLE icon
405
Allegion
ALLE
$14.1B
$42.8M 0.04%
356,221
+7,704
+2% +$841K
PWR icon
406
Quanta Services
PWR
$100B
$42.6M 0.04%
216,710
-14,794
-6% -$2.58M
CGGR icon
407
Capital Group Growth ETF
CGGR
$25B
$42.4M 0.04%
1,682,306
+15,444
+0.9% +$360K
SRCL
408
DELISTED
Stericycle Inc
SRCL
$42.1M 0.03%
905,672
+121,544
+16% +$5.32M
WRB icon
409
W.R. Berkley
WRB
$26.3B
$41.9M 0.03%
1,056,044
+134,907
+15% +$5.3M
BN icon
410
Brookfield
BN
$108B
$41.8M 0.03%
1,862,210
+110,060
+6% +$2.33M
SJM icon
411
J.M. Smucker
SJM
$12.6B
$41.7M 0.03%
282,644
-4,130
-1% -$630K
IWB icon
412
iShares Russell 1000 ETF
IWB
$50.2B
$41.7M 0.03%
171,078
-31,160
-15% -$7.18M
BAX icon
413
Baxter International
BAX
$14.4B
$41.6M 0.03%
912,805
-12,049
-1% -$525K
IEUR icon
414
iShares Core MSCI Europe ETF
IEUR
$9.14B
$41.5M 0.03%
787,995
-5,169
-0.7% -$275K
NTR icon
415
Nutrien
NTR
$31.4B
$41.5M 0.03%
701,977
+212,760
+43% +$13.5M
BFAM icon
416
Bright Horizons
BFAM
$3.84B
$41.2M 0.03%
446,059
+22,397
+5% +$1.89M
BIIB icon
417
Biogen
BIIB
$30.7B
$41.1M 0.03%
144,231
+23,814
+20% +$7.09M
GSK icon
418
GSK
GSK
$104B
$40.9M 0.03%
1,147,932
+21,053
+2% +$755K
SITE icon
419
SiteOne Landscape Supply
SITE
$4.38B
$40.9M 0.03%
244,400
-64,487
-21% -$9.52M
BRO icon
420
Brown & Brown
BRO
$23.8B
$40.9M 0.03%
593,668
+36,208
+6% +$2.3M
CRWD icon
421
CrowdStrike
CRWD
$230B
$40.9M 0.03%
1,112,764
-49,520
-4% -$1.73M
NTAP icon
422
NetApp
NTAP
$39.5B
$40.9M 0.03%
534,751
+123,100
+30% +$8.31M
DLB icon
423
Dolby
DLB
$5.83B
$40.6M 0.03%
485,382
-344
-0.1% -$28.7K
TIP icon
424
iShares TIPS Bond ETF
TIP
$14.7B
$40.5M 0.03%
376,745
-55,569
-13% -$6.05M
IT icon
425
Gartner
IT
$12.1B
$40.4M 0.03%
115,427
-6,980
-6% -$2.27M

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.